current affair
The Russian Direct Investment Fund informed that its deal with the Serum Institute of India envisages the annual production of more than 300 million doses of the COVID-19 vaccine in India starting in September.
from Jagran Josh https://ift.tt/3r7wavD
via IFTTT
Post a Comment